NEO-002

N/A

Report date: 2025/01/26 17:36:23
NME

Base Information

Drug NameNEO-002
Drug Alias Name5-HT2C receptor agonist (NeonMind Biosciences)low-dose psilocybin therapy (NeonMind Biosciences)NEO-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2c (5-HT2c) receptor agonists
TargetsSerotonin 2c (5-HT2c) receptor
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeonMind Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeonMind Biosciences Inc
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A